2 The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Apr 16, 2025
3 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
6 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Feb 06, 2025
Read More Medical Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Apr 16, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Medical K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Apr 08, 2025
